Zepp Health Corporation ZEPP
$4.58
-$0.37-7.48%
NYSE
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 199.95M | 181.18M | 182.65M | 206.12M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 199.95M | 181.18M | 182.65M | 206.12M |
| Cost of Revenue | -- | 124.92M | 111.29M | 112.40M | 128.96M |
| Gross Profit | -- | 75.03M | 69.90M | 70.25M | 77.16M |
| SG&A Expenses | -- | 75.52M | 74.50M | 71.31M | 68.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 245.90M | 230.90M | 229.84M | 243.74M |
| Operating Income | -- | -45.95M | -49.72M | -47.18M | -37.62M |
| Income Before Tax | -- | -63.72M | -67.02M | -62.04M | -37.21M |
| Income Tax Expenses | -- | 13.93M | 13.73M | 13.69M | 2.89M |
| Earnings from Continuing Operations | -- | -77.64 | -80.75 | -75.74 | -40.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 33.00K | 43.00K | 75.20K | 35.20K |
| Net Income | -- | -77.61M | -80.71M | -75.66M | -40.07M |
| EBIT | -- | -45.95M | -49.72M | -47.18M | -37.62M |
| EBITDA | -- | -40.25M | -43.34M | -40.17M | -29.94M |
| EPS Basic | -- | -77.35 | -80.19 | -74.98 | -39.64 |
| Normalized Basic EPS | -- | -1.03 | -1.03 | -1.68 | -1.06 |
| EPS Diluted | -- | -77.35 | -80.19 | -75.10 | -40.91 |
| Normalized Diluted EPS | -- | -1.03 | -1.03 | -1.68 | -1.06 |
| Average Basic Shares Outstanding | -- | 64.10M | 64.53M | 64.72M | 63.74M |
| Average Diluted Shares Outstanding | -- | 4.01M | 4.03M | 4.04M | 3.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |